company background image
SGBHD logo

Supergenics Berhad KLSE:SGBHD Stock Report

Last Price

RM 0.25

Market Cap

RM 28.9m

7D

66.7%

1Y

-50.0%

Updated

13 Mar, 2025

Data

Company Financials

SGBHD Stock Overview

An investment holding company, provides integrated turnkey solutions for the development of cleanrooms used in laboratories and medical centers in Malaysia. More details

SGBHD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Supergenics Berhad Competitors

Price History & Performance

Summary of share price highs, lows and changes for Supergenics Berhad
Historical stock prices
Current Share PriceRM 0.25
52 Week HighRM 0.60
52 Week LowRM 0.15
Beta0.052
1 Month Change4.17%
3 Month Changen/a
1 Year Change-50.00%
3 Year Change-15.25%
5 Year Change-16.67%
Change since IPO-10.71%

Recent News & Updates

Recent updates

Shareholder Returns

SGBHDMY ConstructionMY Market
7D66.7%-3.8%-2.9%
1Y-50.0%14.5%-3.9%

Return vs Industry: SGBHD underperformed the MY Construction industry which returned 12% over the past year.

Return vs Market: SGBHD underperformed the MY Market which returned -5% over the past year.

Price Volatility

Is SGBHD's price volatile compared to industry and market?
SGBHD volatility
SGBHD Average Weekly Movementn/a
Construction Industry Average Movement5.8%
Market Average Movement5.2%
10% most volatile stocks in MY Market10.2%
10% least volatile stocks in MY Market2.7%

Stable Share Price: SGBHD's share price has been volatile over the past 3 months compared to the MY market.

Volatility Over Time: Insufficient data to determine SGBHD's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982n/aBii Chau Tanwww.supergenic.com.my

Supergenics Berhad, an investment holding company, provides integrated turnkey solutions for the development of cleanrooms used in laboratories and medical centers in Malaysia. The company is involved in the provision of administrative health care services; and operation of medical laboratories; and development of medical treatment and wellness products. It also offers technology and manufacturing system development services for cell, gene, and tissue therapies; and management services for cleanrooms.

Supergenics Berhad Fundamentals Summary

How do Supergenics Berhad's earnings and revenue compare to its market cap?
SGBHD fundamental statistics
Market capRM 28.92m
Earnings (TTM)-RM 7.15m
Revenue (TTM)RM 5.37m

5.4x

P/S Ratio

-4.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SGBHD income statement (TTM)
RevenueRM 5.37m
Cost of RevenueRM 3.41m
Gross ProfitRM 1.96m
Other ExpensesRM 9.11m
Earnings-RM 7.15m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.062
Gross Margin36.47%
Net Profit Margin-133.10%
Debt/Equity Ratio142.4%

How did SGBHD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/13 05:37
End of Day Share Price 2025/03/10 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Supergenics Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.